Business Description
PeptiDream Inc
ISIN : JP3836750004
Total Employee Number:
645Description
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.56 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | -6.52 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 4.39 | |||||
Beneish M-Score | -1.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -11.5 | |||||
3-Year FCF Growth Rate | -55 | |||||
3-Year Book Growth Rate | 17.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 34.53 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 8.73 | |||||
9-Day RSI | 14.05 | |||||
14-Day RSI | 19.26 | |||||
3-1 Month Momentum % | -9.42 | |||||
6-1 Month Momentum % | -41.39 | |||||
12-1 Month Momentum % | -46.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.06 | |||||
Quick Ratio | 3.66 | |||||
Cash Ratio | 2.83 | |||||
Days Inventory | 107.84 | |||||
Days Sales Outstanding | 95.53 | |||||
Days Payable | 134.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 2.84 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.42 | |||||
Operating Margin % | -25.12 | |||||
Net Margin % | -18.74 | |||||
EBITDA Margin % | -13.15 | |||||
FCF Margin % | -30.38 | |||||
OCF Margin % | -23.31 | |||||
ROE % | -6.81 | |||||
ROA % | -4.59 | |||||
ROIC % | -7.38 | |||||
3-Year ROIIC % | -246.8 | |||||
ROC (Joel Greenblatt) % | -20.81 | |||||
ROCE % | -7 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 6.74 | |||||
Shiller PE Ratio | 33.71 | |||||
PS Ratio | 6.7 | |||||
PB Ratio | 2.55 | |||||
Price-to-Tangible-Book | 3.23 | |||||
EV-to-EBIT | -25.45 | |||||
EV-to-Forward-EBIT | 14.46 | |||||
EV-to-EBITDA | -46.96 | |||||
EV-to-Forward-EBITDA | 12.59 | |||||
EV-to-Revenue | 6.18 | |||||
EV-to-Forward-Revenue | 6.41 | |||||
EV-to-FCF | -20.5 | |||||
Price-to-GF-Value | 0.6 | |||||
Price-to-Projected-FCF | 1.5 | |||||
Price-to-Median-PS-Value | 0.13 | |||||
| Price-to-Net-Current-Asset-Value | 10.71 | |||||
| Price-to-Net-Cash | 200 | |||||
Earnings Yield (Greenblatt) % | -3.93 | |||||
FCF Yield % | -4.52 | |||||
Forward Rate of Return (Yacktman) % | 23.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PPTDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PeptiDream Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 125.362 | ||
| EPS (TTM) ($) | -0.183 | ||
| Beta | 0.4007 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.47 | ||
| Volatility % | 33.27 | ||
| 14-Day RSI | 19.26 | ||
| 14-Day ATR ($) | 0.063981 | ||
| 20-Day SMA ($) | 6.351 | ||
| 12-1 Month Momentum % | -46.74 | ||
| 52-Week Range ($) | 5.98 - 13.18 | ||
| Shares Outstanding (Mil) | 128.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PeptiDream Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PeptiDream Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 4:1 Stock Split | 2015-06-26 | 28.44 (+0.00%) |
Show
Entries
PeptiDream Inc Frequently Asked Questions
What is PeptiDream Inc(PPTDF)'s stock price today?
The current price of PPTDF is $6.00. The 52 week high of PPTDF is $13.18 and 52 week low is $5.98.
When is next earnings date of PeptiDream Inc(PPTDF)?
The next earnings date of PeptiDream Inc(PPTDF) is .
Does PeptiDream Inc(PPTDF) pay dividends? If so, how much?
PeptiDream Inc(PPTDF) does not pay dividend.
Guru Commentaries on OTCPK:PPTDF
No articles.
Press Release
Articles on PeptiDream Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers